ERBB4 and breast cancer: Among these concordantly methylated genes, several have known tumor-suppressive activities in PCa, including ERBB4, MCPH1, RBMS3, and AKAP12, High DNA methylation levels of ERBB4 have been associated with poor prognosis and aggressive disease in breast cancer patients [44].